IRIS
VINCENZI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 17.199
NA - Nord America 3.870
EU - Europa 1.833
SA - Sud America 411
AF - Africa 92
OC - Oceania 54
AN - Antartide 1
Totale 23.460
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 12.996
US - Stati Uniti d'America 3.681
CN - Cina 1.839
HK - Hong Kong 1.798
GB - Regno Unito 579
IT - Italia 484
BR - Brasile 293
DE - Germania 223
VN - Vietnam 186
IN - India 130
NL - Olanda 117
CA - Canada 115
FI - Finlandia 62
JP - Giappone 58
MX - Messico 56
ZA - Sudafrica 53
AR - Argentina 52
UA - Ucraina 52
AU - Australia 49
TR - Turchia 48
PL - Polonia 47
ES - Italia 35
FR - Francia 35
ID - Indonesia 30
SE - Svezia 28
EE - Estonia 24
CZ - Repubblica Ceca 23
CH - Svizzera 19
AT - Austria 15
BE - Belgio 15
EC - Ecuador 15
CL - Cile 13
LT - Lituania 13
RU - Federazione Russa 13
SA - Arabia Saudita 13
BD - Bangladesh 11
KR - Corea 11
TW - Taiwan 10
CO - Colombia 9
PE - Perù 9
PY - Paraguay 8
SI - Slovenia 8
UZ - Uzbekistan 8
IR - Iran 7
RO - Romania 7
EG - Egitto 6
PH - Filippine 6
AZ - Azerbaigian 5
IL - Israele 5
UY - Uruguay 5
AM - Armenia 4
DM - Dominica 4
IQ - Iraq 4
PT - Portogallo 4
TH - Thailandia 4
BF - Burkina Faso 3
IE - Irlanda 3
LV - Lettonia 3
MA - Marocco 3
ML - Mali 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BY - Bielorussia 2
CY - Cipro 2
DZ - Algeria 2
FK - Isole Falkland (Malvinas) 2
GH - Ghana 2
GR - Grecia 2
GT - Guatemala 2
HT - Haiti 2
HU - Ungheria 2
KE - Kenya 2
LB - Libano 2
LU - Lussemburgo 2
NE - Niger 2
NG - Nigeria 2
OM - Oman 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TL - Timor Orientale 2
YE - Yemen 2
AQ - Antartide 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CU - Cuba 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
Totale 23.433
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.771
Hefei 1.086
Singapore 1.060
Ashburn 802
Boardman 655
London 507
Dallas 440
Shanghai 353
Beijing 224
Los Angeles 150
San Francisco 123
Council Bluffs 117
Munich 101
Rome 96
Amsterdam 79
Ho Chi Minh City 78
Pune 77
Seattle 68
Toronto 67
Santa Clara 59
New York 57
Washington 54
São Paulo 52
Warsaw 46
Hanoi 39
Tokyo 39
Turku 37
Johannesburg 34
Mexico City 32
Brooklyn 31
Chicago 29
Milan 28
Boston 25
Helsinki 25
Melbourne 24
Stockholm 24
Chennai 23
Montreal 22
Brno 20
Secaucus 19
St Louis 17
Ankara 14
The Dalles 14
Charlotte 13
Sydney 13
Canberra 12
Central 12
Hasselt 12
Naples 12
West Jordan 12
Denver 11
Phoenix 11
Rio de Janeiro 10
Atlanta 9
Bologna 9
Hanover 9
Palermo 9
Buenos Aires 8
Manchester 8
Modena 8
New Delhi 8
Riyadh 8
Sona 8
Thái Bình 8
Vienna 8
Frankfurt am Main 7
Guangzhou 7
Haikou 7
Lima 7
Poplar 7
Quito 7
Turin 7
Asunción 6
Biên Hòa 6
Campobasso 6
Da Nang 6
Haiphong 6
Mong Kok 6
Mumbai 6
Padova 6
Redmond 6
Bari 5
Charleston 5
Curitiba 5
Ekimaedori 5
Genoa 5
Ha Long 5
Hangzhou 5
Las Vegas 5
Ljubljana 5
New Taipei 5
Novara 5
Paris 5
San Pietro in Lama 5
Teramo 5
Topeka 5
Yeonsu-gu 5
Andover 4
Baoding 4
Belo Horizonte 4
Totale 9.031
Salva come PNG Salva come JPEG
Nome #
Aspetti etico-clinici del percorso decisionale ed assistenziale per la sedazione palliativa 297
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 241
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 225
Cardiotossicità da antracicline 214
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 214
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 210
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 209
Doctor-patient communication tricks. Ontological study a Campus Bio-Medico University of Rome 208
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 207
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 206
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 205
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 204
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 203
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 198
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 197
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 195
Sarcopenia Does Not Impact the Outcome of Patients with Multiple Myeloma Consolidated with Autologous Hematopoietic Stem Cell Transplantation 194
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 194
Premetastatic niche: ready for new therapeutic interventions? 193
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 192
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 192
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 188
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma 188
Activity of chemotherapy in inflammatory myofibroblastic tumor (IMT): A retrospective analysis within the Italian Rare Tumours Network (RTR). 185
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 185
Prevention of radiotherapy-induced emesis 183
Urinary complications from breast cancer metastasis: case report and review of the literature 182
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 181
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 181
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 180
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 180
Survey on learning needs and preferred sources of information to meet these needs in Italian oncology patients receiving chemotherapy 180
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma 179
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 177
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma 177
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 175
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 172
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 171
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 171
CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients 170
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 169
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 168
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 167
Docetaxel induced pericardial effusion 164
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 155
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 140
Liver harvesting surgical technique for the treatment of retro-hepatic caval thrombosis concomitant to renal cell carcinoma: perioperative and long-term results in 15 patients without mortality 125
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 117
A giant sarcoma of the parotid gland: A case report and review of the literature 116
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 113
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 110
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 107
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 106
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 105
An international survey on the use of guidelines for palliative sedation therapy 103
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 103
'Old' and 'new' drugs for the treatment of cancer pain 101
Circulating endothelial cell (CEC) kinetic in patients with Multiple Myeloma (MM) who receive Au-HSCT (Autologous Hematopoietic Stem Cell Transplantation) 100
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 97
Biological effects of cabozantinib on bone microenvironment 96
Activity of sirolimus in advanced epithelioid hemangioendothelioma (EHE): A retrospective analysis within the Italian Rare Tumor Network (RTR). 95
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 95
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 95
Adenogenesis Factors FGF7, FGF10, FGF23, IFN-τ and HGF in Endometriosis Tissue Respect to Eutopic Endometrium: An Immunohistochemical Study 93
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 93
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 93
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 92
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 92
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 91
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 91
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 91
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 91
Idiosyncratic reaction after oxaliplatin infusion 90
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 90
Infusion of bevacizumab increases the risk of intestinal perforation: results on a series of 143 patients consecutively treated 90
Azygo-tracheal fistula in a complete implantable central venous system 90
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 90
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 90
Locally recurrent extraskeletal myxoid chondrosarcoma of the shoulder: a case of complete neoadjuvant radiotherapy response 89
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 89
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 88
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 88
Atypical chronic head and neck pain: don't forget Eagle's syndrome 88
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 87
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 87
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 87
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 87
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 86
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 86
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 86
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl) 80
Persisting perianal ulcer after radiotherapy for anal cancer: recurrence of disease or late radiation-related complication? 80
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 79
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 78
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 77
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 76
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 70
Classic Kaposi Sarcoma: to treat or not to treat? 69
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 66
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 64
Totale 13.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 216.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 216.792
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022753 0 9 12 4 49 12 10 9 24 23 26 575
2022/2023194 23 7 3 14 7 8 19 15 15 7 69 7
2023/20241.888 49 213 155 165 156 766 27 113 27 53 81 83
2024/202517.397 277 217 719 138 146 420 296 76 1.521 1.321 5.821 6.445
2025/20263.401 1.506 684 1.068 143 0 0 0 0 0 0 0 0
Totale 23.633